GelSana Pitches at Media Pitch Day at Fitzsimons Innovation Community
GelSana was selected as one of the companies to pitch at Fitzsimons Innovation Community Media Pitch…
News
Read MoreGelSana Pitches at Media Pitch Day at Fitzsimons Innovation Community
GelSana’s Cleragel Selected as a Top 10 Coolest Product Made in Colorado!
The Colorado Chamber of Commerce has announced the top 10 finalists for its second annual Coolest Thing…
GelSana Presents at MHSRS Conference, August 2023
Adam Rocker was honored to present a research poster highlighting the capabilities of our wound healing…
GelSana Pitches at California Life Sciences Innovation Showcase, Berkeley, June 2023
GelSana was excited to pitch at the CLS Innovation Showcase at University of California, Berkeley Bakar…
GelSana Attends BIO / RESI Conference in Boston, June 2023
GelSana attended BIO and RESI conferences in Boston in June 2023. Melissa Krebs was invited to…
GelSana’s Next Frontier: AFWERX SBIR Phase I Funding Award Ignites Innovation in Zwitterionic Hydrogels for Enhanced Military and Civilian Wound Healing
GelSana is thrilled to announce that our company has been selected for AFWERX SBIR funding through…
GelSana Team Showcases Hydrogel Technology at the Symposium on Advanced Wound Care (SAWC) | Wound Healing Society (WHS) Conference Spring 2023
The SAWC event was an incredible platform for us to showcase our groundbreaking wound healing hydrogel…
GelSana Secures NIH SBIR Phase I Funding for Sustained Anti-Inflammatory Cytokine Delivery Hydrogel
GelSana is proud to announce that we have been awarded NIH SBIR Phase I funding through…
Melissa Krebs Featured in 5280 Magazine, April 2023, “20 Colorado Health Startups That Will Change Your Life”
The 5280 Denver’s Mile High Magazine article discusses the underfunding of companies started solely by women…